ABOUT ECTICA TECHNOLOGIES
Ectica Technologies AG is a Swiss supplier of hydrogel-based tools and technology to the biopharmaceutical industry and bioresearch institutes. Our patented 3DProSeed® technology combines the biological relevance of cell-based assays in hydrogels with the highest workflow integration level in drug discovery. Ectica Technologies is a spin-off company of the ETH Zurich and University of Zurich.
3DProSeed® Hydrogel Plate
Our 3DProSeed® microtiter plate combines the advantages of hydrogel-based cultures with the
simplicity and workflow integration of standard polystyrene cultureware.
Our plate contains pre-assembled synthetic hydrogels, delivered to you hydrated, ready for cell seeding.
Hydrogel-based cultures have never been so
simple to establish.
Ectica Technologies engages in contract research and development directed to the integration of the 3DProSeed technology in drug discovery programs.
We also engage in development and production of OEM hydrogel solutions, which can be customised in terms of hydrogel chemistry, product format, usage and branding.
Merck KGaA is using our 3DProSeed technology to develop complex co-cultures in 3D, to mimic the physiology of human cancers in vitro, leading to clinically relevant data early in the drug discovery stages.